Last edition
News about " Elecsys pTau217"
Roche's Elecsys pTau217 Gets US FDA Clearance for Alzheimer's Assessment
Roche’s Elecsys pTau217 receives US Food and Drug Administration (FDA) clearance as a blood test for Alzheimer’s amyloid pathology assessment across primary and specialty care settings.
Elecsys PTau217 | 25/08/2026 | By News Bureau
Roche Receives CE Mark for Blood-Based Alzheimer's Diagnostic Test
Roche receives CE Mark approval for Elecsys pTau217, a blood-based Alzheimer’s diagnostic test developed with Eli Lilly, aimed at enabling earlier and less invasive detection of amyloid pathology in patients with cognitive decline.
Elecsys PTau217 | 13/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy